Detection of Fossil and Biogenic Methane at Regional Scales Using Atmospheric Radiocarbon.

Regional emissions of methane and their attribution to a variety of sources presently have large uncertainties. Measurements of radiocarbon (14C) in methane (CH4) may provide a method for identifying regional CH4 emissions from fossil versus biogenic sources because adding 14C-free fossil carbon reduces the 14C/C ratio (Δ14CH4) in atmospheric CH4 much more than biogenic carbon does. We describe an approach for estimating fossil and biogenic CH4 at regional scales using atmospheric Δ14CH4 observations. As a case study to demonstrate expected Δ14CH4 and Δ14CH4-CH4 relationships, we simulate and compare Δ14CH4 at a network of sites in California using two gridded CH4 emissions estimates (Emissions Database for Global Atmospheric Research, EDGAR, and Gridded Environmental Protection Agency, GEPA) and the CarbonTracker-Lagrange model for 2014, and for 2030 under business-as-usual and mitigation scenarios. The fossil fraction of CH4 (F) is closely linked with the simulated Δ14CH4-CH4 slope and differences of 2-21% in median F are found for EDGAR versus GEPA in 2014, and 7-10% for business-as-usual and mitigation scenarios in 2030. Differences of 10% in F for >200 ppb of added CH4 produce differences of >10‰ in Δ14CH4, which are likely detectable from regular observations. Nuclear power plant 14CH4 emissions generally have small simulated median influences on Δ14CH4 (0-7‰), but under certain atmospheric conditions they can be much stronger (>30‰) suggesting they must be considered in applications of Δ14CH4 in California. This study suggests that atmospheric Δ14CH4 measurements could provide powerful constraints on regional CH4 emissions, complementary to other monitoring techniques.

Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma.

Intravascular large B-cell lymphoma (IVLBCL) is a distinct disease entity with the peculiar characteristic that tumor cells proliferate within vessels. Despite recent advances in understanding the disease from clinical aspects, the underlying pathogenesis remains unknown. Here we demonstrate analyses of IVLBCL biology using four xenograft mouse models established from primary IVLBCL samples. In all four models, the main characteristic of IVLBCL tumor cell proliferation within vessels was retained. Time-lapse engraftment analyses revealed that the tumor cells initially engrafted and proliferated in the sinusoids and vessels in the liver and then engrafted and proliferated in multiple organs. Intriguingly, serial passage of tumor cells from the adrenal gland of a transplanted mouse developed from primary patient bone marrow cells into a second mouse showed that the tumor cells mainly distributed into the adrenal gland in the second mouse, implying the existence of clonal selection and/or evolution at engraftment of a specific organ. Gene expression profiling analyses demonstrated that the gene set associated with cell migration was enriched for normal peripheral blood B cells, indicating that inhibition of cell migration might be involved in IVLBCL pathogenesis. In conclusion, the mouse xenograft models described here are essential tools for uncovering IVLBCL biology.

Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening.

Of the 65 328 pregnancies of South Australian mothers screened by the South Australian Maternal Serum Antenatal Screening (SAMSAS) Programme between 1 January 1991 and 31 December 1997, 3431 (5.25%) were declared at increased risk of fetal Down syndrome. Fetal or neonatal karyotype was determined in 2737/3431 (79.8%) of these pregnancies, including 16 with early fetal loss. Interrogation of the database of the South Australian Neonatal Screening Service showed 643 live-born infants whose phenotype was not subsequently questioned among the 694 pregnancies whose karyotype was not determined. Of the remaining 51/3431 pregnancies, 19 ended in early fetal loss without karyotyping and no newborn screening or other records could be found for 32 cases. The 129 instances of abnormal karyotype found were Down syndrome (84), trisomy 18 (four), trisomy 13 (three), triploidy (two), female sex chromosome aneuploidy (six) and male sex chromosome aneuploidy (five), inherited balanced rearrangements (19), mosaic or de novo balanced abnormalities (four) and unbalanced karyotypes (two). In the pregnancies declared at increased risk of fetal Down syndrome, only the karyotype for Down syndrome occurred with a frequency greater than that expected for the general, pregnant population.

Homozygotes for FRA16B are normal.

Homozygotes for the rare folate-sensitive autosomal fragile sites have never been recorded. Two non-folate-sensitive rare fragile sites (FRA10B and FRA17A) have been previously recorded in normal individuals. We document two unrelated normal individuals who are homozygotes for the rare fragile site FRA16B and record the patterns of induction of this fragile site with berenil. The existence of normal homozygotes for FRA16B suggests that this fragile site is not within a gene essential for normal development.

Tuberculosis: a strategy to detect and treat new and reactivated infections.

Adults age 65 and older are among those most likely to develop active tuberculosis (TB). Classic symptoms include fatigue, anorexia, weight loss, and a persistent low-grade fever. Older patients may have atypical symptoms, and studies show they have significantly more weight loss and more crackles in the lung fields than younger patients. Skin testing is a useful screening tool and is indicated in individuals suspected of active TB, those in whom prophylaxis would be considered, and nursing home residents. Definitive diagnosis is based on a positive sputum culture. Combination therapy with first-line antituberculous drugs is usually effective and well-tolerated in older patients. Preventive therapy is indicated in tuberculin reactors who have been recently infected.

Abscisic acid binding to subcellular fractions from leaves of Vicia faba.

A centrifugation binding assay has been used to demonstrate the binding of [(3)H] (±) abscisic acid to membrane-rich fractions prepared from leaves of Vicia faba L. Kinetic analysis of this binding shows evidence of saturation of binding sites with increasing concentration of ligand. Scatchard analysis of these data yields a biphasic plot possibly indicating the presence of two types of binding sites. The dissocation constant for the high affinity site has been calculated to be 3.5×10(-8) mol 1(-1).

Studies on the role of abscisic acid in the initiation of bud dormancy in Alnus glutinosa and Betula pubescens.

The effects of leaf-applied (+-)-abscisic acid on the growth and dormancy of Betula pubescens Ehrh. and Alnus glutinosa Gaertn. growing under long days provide no evidence that leaf-applied abscisic acid induces or promotes the formation of resting buds in these species. Radiotracer studies show that a small percentage of the radioactivity applied as [2-(14)C]abscisic acid to the leaves accumulates in the apical region of the shoot. Of the radioactivity that was recovered from this region after 8 days, less than 10% was chromatographically similar to [2-(14)C]abscisic acid. The significance of these results with respect to the role of abscisic acid in regulating the induction of bud dormancy is discussed.